Schedule 13D ownership disclosure

REGULUS THERAPEUTICS INC

Security class unavailable · CUSIP: 75915K200

Event date: 2019-12-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,935,322
Percent of class
29.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-20-000007
Form type
SC 13D/A
Filer
Regulus Therapeutics Inc.
CIK
CIK 1505512
Filed
Jan 03, 2020
Reporting period
Dec 24, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub